IAS

Programs: Nih : the 9th international aids society conference on hiv science (ias 2017) took place at the palais des congrs, in paris, france, from 23 to 26 july 2017, chaired by linda-gail bekker and jean-franois delfraissy. It was organised by the international aids society (ias) in partnership with anrs (the french national agency for research on aids and viral hepatitis), bringing together more than 6000 leading scientists, researchers and hiv professionals from around the world. The conference featured more than 1800 abstracts selected for oral and poster presentations out of over 4300 submissions, in addition to plenary sessions and satellite symposia. Prevention was high on the agenda of this year's conference. Data relevant to children, adolescents and adults with hiv on recent advances in the understanding of viralhost interactions, targeting of the hiv reservoir, new oral and long-acting antiretroviral drugs, strategies for simplification of treatment regimens, immune-based therapies, pre-exposure prophylaxis (prep) to hiv, prevention of mother-to-child transmission, prophylactic and therapeutic vaccines, as well as comorbidities including hepatitis, were presented with an emphasis on translating science into practice and policies.

bringing home the science: the gilead grant of us$ 239,495 supporting the bringing the science home programme aims to: - empower a group of targeted africa-based hiv professionals in implementing new strategies that align with the latest hiv science, - create a space where national hiv experts can discuss local specificities and programmes face to face with global experts on hiv. To achieve these objectives, the ias is implementing four sets of meetings, each including: - a one-day symposium introducing latest scientific research results; - a half-day meeting between scientific experts and key public health implementation agencies on how to effectively incorporate new science and new approaches into national plans. In addition to the nigeria & senegal meetings held in 2016, two meetings were held in 2017: one in morocco (march) and one in kenya (may). Bringing the science home gathered in 2016-2017 over 1,170 hiv professionals, government and regional leaders, public health specialists and hiv programme managers. The programme for each symposium included presentations delivered by national, regional and international specialists on two or more of the following key topics:- new hiv prevention technologies (in particular prep);- hiv co-infections specifically hcv;- hiv cure the meetings offered a safe place to share and reflect on current implementation practices and to define 2017-2019 priorities for the countries represented. It also allowed to initiate a process to develop a "call to action 2017-2019" between hiv researchers, programme implementers and policy makers.

ias towards an hiv cure initiative supported by gilead $40,000 mission: to drive concerted efforts to accelerate global scientific research and engagement towards a cure for hiv. The toolbox of interventions for fighting the global hiv pandemic has grown exponentially since the discovery of the virus, but a cure has remained beyond our grasp. In recent years, however, research to develop a cure for hiv or long-term remission has made promising progress, galvanizing researchers, advocates and community members alike. To that end, the mission of the ias towards an hiv cure initiative is to drive concerted efforts to accelerate global scientific research and engagement towards a cure for hiv.

hiv advocates